OQSILLARNING TIBBIYOTDAGI AHAMIYATI
Keywords:
oqsillar, proteomika, diagnostika, biofarmatsevtika, regenerativ tibbiyot.Abstract
Ushbu ilmiy ishda oqsillarning tibbiyotdagi ahamiyati keng tahlil qilinadi. Oqsillarning diagnostik, terapevtik va farmakologik qo‘llanilishi bo‘yicha xalqaro va mahalliy tadqiqotlar tahlil qilinib, ularning zamonaviy tibbiyotda tutgan o‘rni yoritiladi. Molekulyar biologiya va proteomika yutuqlari asosida oqsillarning klinik amaliyotga integratsiyasi, oqsil biomarkerlari yordamida kasalliklarni erta tashxislash va oqsillar asosidagi dori vositalarining ahamiyati tahlil qilinadi. Tadqiqotda biotexnologiyaning so‘nggi yutuqlari, oqsillar bilan bog‘liq diagnostika usullari va regenerativ tibbiyotdagi imkoniyatlar o‘rganilgan.
Downloads
References
Watson, J. D., & Crick, F. H. C. (1953). Molecular structure of nucleic acids: A structure for deoxyribose nucleic acid. Nature, 171(4356), 737-738.
Sanger, F. (1980). Determination of nucleotide sequences in DNA. Science, 209(4453), 145-150.
Lehninger, A. L. (1975). Biochemistry: The molecular basis of cell structure and function. Worth Publishers.
Berg, J. M., Tymoczko, J. L., & Stryer, L. (2015). Biochemistry (8th ed.). W. H. Freeman.
Branden, C., & Tooze, J. (1999). Introduction to Protein Structure (2nd ed.). Garland Science.
Global Protein Research Institute. (2022). Protein-based therapeutics and their clinical applications. Journal of Molecular Medicine, 130(4), 567-589.
Harvard Medical School. (2023). Protein functions and disease mechanisms: A modern proteomics approach. Annual Review of Biomedical Sciences, 18, 98-115.
Баев, А. Н. (1988). Молекулярная биология синтеза белка. Москва: Наука.
Георгиев, Г. Н. (2005). Молекулярные механизмы экспрессии белков в клетке. Биохимия, 70(5), 520-534.
Архангельский, И. М. (2010). Клиническое применение белковых биомаркеров. Российский журнал молекулярной медицины, 8(2), 210-225.
Власов, К. К. (2018). Протеомика и биоинформатика в диагностике заболеваний. Журнал медицинских исследований, 45(3), 180-195.
Joraboyev, T. Y. (1998). Immunological aspects of protein interactions in human biology. Uzbekistan Journal of Biomedical Research, 12(3), 75-89.
Karimov, Sh. R. (2005). Pharmaceutical approaches to protein-based drug development in Uzbekistan. Journal of Pharmacy and Therapeutics, 22(4), 201-218.
Safarov, A. (2012). Clinical significance of protein biomarkers in cardiovascular diseases. Uzbekistan Medical Journal, 19(6), 320-336.
Mamatqulov, X. (2019). Advancements in proteomic technologies for personalized medicine in Uzbekistan. Scientific Reports of Uzbek Biomedicine, 30(2), 145-162.
O‘zbekiston Respublikasi Sog‘liqni Saqlash Vazirligi (2022). O‘zbekistonda tibbiy proteomika va biotexnologiya rivoji bo‘yicha hisobot. Toshkent.
WHO (2022). Global health report: Protein malnutrition and its impact on public health. Geneva, Switzerland: World Health Organization.
National Institutes of Health (NIH) (2023). Protein-based therapeutics in modern medicine: Trends and innovations. Bethesda, MD: NIH Press.
FDA (2023). Regulatory considerations for protein-based drugs and biologics. Washington, DC: U.S. Food and Drug Administration.
PubMed Central. (2023). Recent developments in protein engineering and therapeutic applications. Journal of Molecular Biology, 432(8), 1523-1545.
